Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Fatima Tarrahi
Dutch Medicines Evaluation Board, The Netherlands, Netherlands
Poster(s):
(173) Safety-Related Drug Label Changes After Large Cardiometabolic Trials. A Review of European Public Assessment Reports
Sunday, August 28, 2022
8:00 AM – 1:45 PM
CEST